Multiple system atrophy (MSA) is an adult-onset, fatal disease, with a constellation of autonomic, cerebellar, and pyramidal symptoms, including parkinsonism.1,2 Pathologically, MSA is characterised by α-synuclein-positive inclusion bodies that form in glial cells of affected brain regions, including the striatonigral and/or olivopontocerebellar systems.1,3
Example differential diagnosis – multiple system atrophy (MSA)
